drugset / Trial / NCT01938092

Vaginal Diazepam for the Treatment of Female Pelvic Pain

NCT01938092

Phase 2 Completed 50 enrolled Raymond Foster
RandomizedParallel-groupTriple-blindTreatment

Summary

To determine the efficacy of intravaginal diazepam for the treatment of pelvic pain associated with pelvic floor hypertonic disorder.

Timeline

Start
2013-09
Primary completion
2017-03
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diazepam Small molecule 10 mg Other

Indications